Annexin-A1: Therapeutic potential in microvascular disease
Annexin-A1 (ANXA1) was first discovered in the early 1980's as a protein, which mediates (some of the) anti-inflammatory effects of glucocorticoids. Subsequently, the role of ANXA1 in inflammation has been extensively studied. The biology of ANXA1 is complex and it has many different roles in b...
Main Authors: | Purvis, G, Solito, E, Thiemermann, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Frontiers Media
2019
|
Similar Items
-
Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes
by: Purvis, G, et al.
Published: (2017) -
Therapeutic potential for targeting Annexin A1 in fibrotic diseases
by: Zhibin Yan, et al.
Published: (2022-11-01) -
Annexin 1 and the regulation of endocrine function.
by: John, C, et al.
Published: (2004) -
Annexin A1 in the brain--undiscovered roles?
by: Solito, E, et al.
Published: (2008) -
Annexin 1, glucocorticoids, and the neuroendocrine-immune interface.
by: Buckingham, J, et al.
Published: (2006)